Please assess the completion status of the following clinical trial:

Trial Title: Intraperitoneal Ropivacaine Irrigation in Bariatric Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Body mass index (BMI) \>40 Kg/m2~* BMI \> 35 Kg/m2 with the presence of comorbidities associated to obesity.~Exclusion Criteria:~* patients undergoing other bariatric techniques or revisional surgery~* allergy to local anesthetics~* severe underlying cardiovascular diseases~* chronic renal failure~* hepatic dysfunction~* previous foregut surgery~* patients with any contraindication for bariatric surgery.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ropivacaine irrigation (Type: EXPERIMENTAL): Using a standard irrigation device, 300 mg total of ropivacaine in 200ml normal saline will be instilled into the abdomen after surgical dissection, just before abdominal wall closure. Under direct visualization, the solution is delivered over the oesophageal hiatus, over both anastomoses and in both subdiaphragmatic spaces.
- Normal saline irrigation (Type: PLACEBO_COMPARATOR): Using a standard irrigation device, 200ml normal saline will be instilled into the abdomen after surgical dissection, just before abdominal wall closure. Under direct visualization, the solution is delivered over the oesophageal hiatus, over both anastomoses and in both subdiaphragmatic spaces.

Based on this trial design, predict the completion outcome and termination type (if applicable).